Market Cap

PolyPid Ltd. Market Capitalization:

$72.4 Million

USD as of Jan. 1, 2026

business PolyPid Ltd. Company Profile

PolyPid Ltd. Main Stock Listing

NASDAQ: PYPD

Market Capitalization History of PolyPid Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of PolyPid Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $72.4 M 227.26%
Jan. 1, 2025 $22.1 M 72.80%
Jan. 1, 2024 $12.8 M -23.41%
Jan. 1, 2023 $16.7 M -80.49%
Jan. 1, 2022 $85.6 M -52.50%
Jan. 1, 2021 $180.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

PolyPid Ltd. Categories

Israel languages Healthcare languages Biotechnology
Israel Healthcare Israel Biotechnology

Stocks & Indices

PolyPid Ltd. has the following listings and related stock indices.


Stock: NASDAQ: PYPD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.